| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.016 | 0.9 |